Table 2.

Select plasma NMR measurements of systemic inflammation, insulin resistance, lipids, and lipoproteins.

	CLL-FIT (N = 10)	CLL-UNFIT (N = 10)	p-Value	95% CI	Effect Size (d)
Inflammation
GlycA (µmol/L)	354.7 ± 31.1	442.0 ± 97.0	0.014	−155.0, −19.6	1.21
Insulin Resistance
LP-IR (1-100)	33.7 ± 18.1	65.7 ± 22.2	0.007	−54.3, −9.7	1.58
Triglycerides
Total Triglycerides (mg/dL)	101.4 ± 40.6	165.2 ± 72.0	0.025	−118.7, 8.9	1.09
TRL Triglycerides (mg/dL)	78.1 ± 38.8	143.4 ± 67.7	0.016	−117.1, −13.5	1.18
Total TRLP (nmol/L)	127.6 ± 58.4	189.8 ± 70.8	0.046	−123.2, −1.2	0.96
Large (nmol/L)	2.5 ± 3.4	8.9 ± 6.2	0.011	−11.1, −1.7	1.28
Very Small (nmol/L)	73.4 ± 38.4	124.4 ± 63.7	0.044	−100.4, −1.6	0.97
Cholesterol (mg/dL)
Total Cholesterol	194.4 ± 29.1	195.4 ± 39.4	0.949	−33.5, 31.5	0.03
TRL Cholesterol	22.5 ± 10.8	34.9 ± 13.3	0.034	−23.8, −1.0	1.02
LDL Cholesterol	106.3 ± 25.7	105.5 ± 29.7	0.949	−25.3, 26.9	0.03
HDL Cholesterol	65.5 ± 10.0	54.8 ± 11.6	0.040	0.5, 20.9	0.99
HDL-P (µmol/L)
Total	24.7 ± 2.4	23.8 ± 4.2	0.559	−2.3, 4.1	0.26
Large	3.4 ± 1.4	1.9 ± 1.6	0.043	0.1, 2.9	1.00
Lipoprotein Size (nm)
TRL	43.7 ± 4.7	50.3 ± 7.2	0.027	−12.3, −0.9	1.09
LDL	20.8 ± 0.4	20.4 ± 0.4	0.059	0.02, 0.8	1.00
HDL	9.2 ± 0.4	8.8 ± 0.5	0.073	−0.03, 0.8	0.88

LP-IR (Lipoprotein–Insulin Resistance); TRL (Triglyceride-Rich Lipoprotein); TRLP (Triglyceride-Rich Lipoprotein Particle); HDL (High-Density Lipoprotein); LDL (Low-Density Lipoprotein), BCAA (Branch-Chain Amino Acid). Bolded values represent significant differences between groups. Data are the mean ± SD.